Even if HLBCs showed differences with both HER2-negative and HER2-positive carcinomas, intra-group analyses revealed overlapping features between score 0 and HLBC-1 cases, whereas score HLBC-2 showed an increasing differential gene expression that reached the highest levels of diversity for HLBC-2E carcinomas. Here, ERBB2 is linked to carcinoma.